These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4453524)

  • 1. [Blood-level of prothionamide following oral administratton of prothionamide alone or in combination with isoniazid and/or with diamino-diphenylsulfon].
    Franz H; Urbanczik R; Stoll K; Müller U
    Prax Pneumol; 1974 Nov; 28(11):605-12. PubMed ID: 4453524
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study (tolerance and effectiveness) of classic antituberculous therapy (P.A.S.-streptomycin-isoniazid) and a new combination (prothionamide-streptomycin-isoniazid)].
    Charpin J; Taranger J; Boutin C; Girbal JP
    Mars Med; 1969; 106(11):895-7. PubMed ID: 5407168
    [No Abstract]   [Full Text] [Related]  

  • 3. Failure of a prothionamide-containing oral antituberculosis regimen.
    Langton ME; Cowie RL
    S Afr Med J; 1985 Dec; 68(12):881. PubMed ID: 4071346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prothionamide and ethambutol in triple treatment of pulmonary tuberculosis].
    Freour P; Nacef T; Fourcaud R; Belhassime T; Kissel
    Therapie; 1970; 25(3):593-8. PubMed ID: 5431850
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of severe open cavitary pulmonary tuberculosis with a combination of rifampicin and isoprodian (author's transl)].
    Pereira V
    Prax Pneumol; 1976 Sep; 30(9):584-7. PubMed ID: 967829
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prothionamide in the combination therapy of tuberculosis].
    Sighart H; Opl G; Koppensteiner G
    Prax Pneumol; 1970 May; 24(5):295-300. PubMed ID: 5419124
    [No Abstract]   [Full Text] [Related]  

  • 7. [Haemoglobin levels during prolonged treatment with isoprodian, a combination of isoniazid, prothionamide and diaphenylsulphone (author's transl)].
    Hoose C
    Prax Pneumol; 1976 Jul; 30(7):435-8. PubMed ID: 967821
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience with isoprodian in the treatment of adult pulmonary tuberculosis (author's transl)].
    Orlowski EH
    Prax Pneumol; 1976 Apr; 30(4):224-9. PubMed ID: 785435
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term prothionamide compliance: a study carried out in India using a combined formulation containing prothionamide, dapsone and isoniazid.
    Ellard GA; Kiran KU; Stanley JN
    Lepr Rev; 1988 Jun; 59(2):163-75. PubMed ID: 3246926
    [No Abstract]   [Full Text] [Related]  

  • 10. On the mechanism of the antimycobacterial activity of isoniazid + prothionamide + dapsone (Isoprodian).
    Urbanczik R
    Chemotherapy; 1979; 25(5):261-7. PubMed ID: 477453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethionamide, prothionamide and thiacetazone self-administration. Studies of patient compliance using isoniazid-marked formulations.
    Stanley JN; Pearson JM; Ellard GA
    Lepr Rev; 1986 Mar; 57(1):9-18. PubMed ID: 2422517
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study in man of the variations in relation to time of the blood levels of prothionamide (1321 TH) and its sulfoxide (1406 TH) after rectal administration].
    Aiache JM; Cheminat JC; Ghaye-Roquet
    Sem Ther; 1967 Mar; 43(3):169-71. PubMed ID: 5601791
    [No Abstract]   [Full Text] [Related]  

  • 13. [Isoniazio, prothionamide and diafenylsulphone (isoprodian) in the therapy of previously untreated pulmonary (author's transl)].
    Müller W
    Prax Pneumol; 1976 Mar; 30(3):157-64. PubMed ID: 785434
    [No Abstract]   [Full Text] [Related]  

  • 14. [A new therapeutic approach to open pulmonary tuberculosis with a combination of isoniazid, prothionamid and dapson (author's transl)].
    González Montaner LF; Garay C; Abbate EH; Albareda MA
    Prax Klin Pneumol; 1978 Jul; 32(7):488-90. PubMed ID: 98759
    [No Abstract]   [Full Text] [Related]  

  • 15. [Concentration of ethionamide and prothionamide in the blood of patients with pulmonary tuberculosis].
    Bialik IB; Kalabukha AV
    Vrach Delo; 1973 Nov; 11():97-100. PubMed ID: 4206857
    [No Abstract]   [Full Text] [Related]  

  • 16. [Isoprodian in ambulatory therapy of pulmonary tuberculosis].
    Opl G; Novak M
    Prax Klin Pneumol; 1980 Dec; 34(12):715-8. PubMed ID: 7465531
    [No Abstract]   [Full Text] [Related]  

  • 17. [Haematological effects of isoprodian (author's transl)].
    Peters M; Papageogiou A
    Prax Pneumol; 1976 Jul; 30(7):430-4. PubMed ID: 967820
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of concentration of ethionamide and prothionamide in the blood of patients with pulmonary tuberculosis by polarographic method].
    Tikhonov VA; Grigaliunas AP; Guzeeva SA
    Probl Tuberk; 1976 May; (5):75-8. PubMed ID: 951413
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunologic aspects of myocardial damage during long-term administration of antitubercular preparations].
    Iakovleva TA; Red'kin IuV; Dolgikh VT; Sokolova TF
    Probl Tuberk; 1983 Jul; (7):31-4. PubMed ID: 6634675
    [No Abstract]   [Full Text] [Related]  

  • 20. [A preliminary report on the clinical efficacy of isoprodian (author's transl)].
    Opl G; Benkö M
    Prax Pneumol; 1976 Mar; 30(3):154-7. PubMed ID: 785433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.